Evidence map›Paper›PMID 39043663›Full record

ArticleNature communications2024

PARP10 promotes the repair of nascent strand DNA gaps through RAD18 mediated translesion synthesis.

Jude B Khatib, Ashna Dhoonmoon, George-Lucian Moldovan, Claudia M Nicolae

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Insights into Molecular Mechanisms of Polyphenolic Compounds fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jude B Khatib *Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.
Ashna Dhoonmoon *Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.ORCID 0000-0001-9661-4477
George-Lucian MoldovanDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.ORCID 0000-0003-3825-149X
Claudia M NicolaeDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. cmn14@psu.edu.ORCID 0000-0003-4933-5496

Funding

The Role of Mono-ADP-Ribosylation by PARP14 in RadioresistanceR01ES026184 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI George Lucian Moldovan · 2016 to 2026
$3.6M
The role of DNA damage tolerance pathways in human cellsR01GM134681 · NIGMS · UNIVERSITY OF VIRGINIA · PI George Lucian Moldovan, Claudia M Nicolae · 2019 to 2026
$3.0M
The role of PARP10 in alleviating replication stress and promoting cellular proliferation and tumorigenesisR01CA244417 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI NICOLAE, CLAUDIA M · 2021 to 2025
$1.8M
NCI NIH HHS R01 CA244417NIEHS NIH HHS R01 ES026184NIGMS NIH HHS R01 GM134681U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA244417U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) R01ES026184U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM134681
6 · The paper itself

Abstract

Replication stress compromises genomic integrity. Fork blocking lesions such as those induced by cisplatin and other chemotherapeutic agents arrest replication forks. Repriming downstream of these lesions represents an important mechanism of replication restart, however the single stranded DNA (ssDNA) gaps left behind, unless efficiently filled, can serve as entry point for nucleases. Nascent strand gaps can be repaired by BRCA-mediated homology repair. Alternatively, gaps can also be filled by translesion synthesis (TLS) polymerases. How these events are regulated is still not clear. Here, we show that PARP10, a poorly-characterized mono-ADP-ribosyltransferase, is recruited to nascent strand gaps to promote their repair. PARP10 interacts with the ubiquitin ligase RAD18 and recruits it to these structures, resulting in the ubiquitination of the replication factor PCNA. PCNA ubiquitination, in turn, recruits the TLS polymerase REV1 for gap filling. We show that PARP10 recruitment to gaps and the subsequent REV1-mediated gap filling requires both the catalytic activity of PARP10, and its ability to interact with PCNA. We moreover show that PARP10 is hyperactive in BRCA-deficient cells, and its inactivation potentiates gap accumulations and cytotoxicity in these cells. Our work uncovers PARP10 as a regulator of ssDNA gap filling, which promotes genomic stability in BRCA-deficient cells.

Indexed as

DNA-Binding ProteinsDNA RepairDNA ReplicationDNA, Single-StrandedPoly(ADP-ribose) PolymerasesProliferating Cell Nuclear AntigenUbiquitinationUbiquitin-Protein LigasesBRCA1 ProteinBRCA2 ProteinCell Line, TumorDNA DamageDNA-Directed DNA PolymeraseHEK293 CellsHumansNucleotidyltransferasesBRCA1 ProteinBRCA2 ProteinBRCA2 protein, humanDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA, Single-StrandedNucleotidyltransferasesPARP10 protein, humanPCNA protein, humanPoly(ADP-ribose) PolymerasesProliferating Cell Nuclear AntigenProto-Oncogene ProteinsRAD18 protein, humanREV1 protein, humanUbiquitin-Protein LigasesY-Family DNA Polymerases

Identifiers

PMID39043663
PMCPMC11266678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.